Abstract
Rifampin reversibly inhibits the intracellular replication of a VSV mutant, whereas a revertant variant selected from this viral population, as well as the wild strain, are not affected by this drug. Rifampin inhibits transcriptase activity of the sensitive mutant only and, consequently, total viral RNA synthesis decreases significantly in the cells.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baltimore D., Huang A. S., Stampfer M. Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A. 1970 Jun;66(2):572–576. doi: 10.1073/pnas.66.2.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grado C., Ohlbaum A. The effect of rifampicin, actinomycin D and mitomycin C on poliovirus and foot-and-mouth disease virus replication. J Gen Virol. 1973 Nov;21(2):297–303. doi: 10.1099/0022-1317-21-2-297. [DOI] [PubMed] [Google Scholar]
- Hartmann G., Honikel K. O., Knüsel F., Nüesch J. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Biochim Biophys Acta. 1967;145(3):843–844. doi: 10.1016/0005-2787(67)90147-5. [DOI] [PubMed] [Google Scholar]
- Heller E., Argaman M., Levy H., Goldblum N. Selective inhibition of vaccinia virus by the antibiotic rifampicin. Nature. 1969 Apr 19;222(5190):273–274. doi: 10.1038/222273a0. [DOI] [PubMed] [Google Scholar]
- Hirschman S. Z. Inhibitors of viral nucleic acid transcriptases. Trans N Y Acad Sci. 1971 Jun;33(6):595–606. doi: 10.1111/j.2164-0947.1971.tb02625.x. [DOI] [PubMed] [Google Scholar]
- Katz E., Moss B. Vaccinia virus structural polypeptide derived from a high-molecular-weight precursor: formation and integration into virus particles. J Virol. 1970 Dec;6(6):717–726. doi: 10.1128/jvi.6.6.717-726.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- McSharry J. J., Wagner R. R. Lipid composition of purified vesicular stomatitis viruses. J Virol. 1971 Jan;7(1):59–70. doi: 10.1128/jvi.7.1.59-70.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moreau M. C. Action de la rifampicine sur le virus de la stomatite vésiculaire. C R Acad Sci Hebd Seances Acad Sci D. 1972 Jan 24;274(4):611–613. [PubMed] [Google Scholar]
- Pennington T. H., Follett E. A., Szilágyi J. F. Events in vaccinia virus-infected cells following the reversal of the antiviral action of rifampicin. J Gen Virol. 1970 Dec;9(3):225–237. doi: 10.1099/0022-1317-9-3-225. [DOI] [PubMed] [Google Scholar]
- Subak-Sharpe J. H., Timbury M. C., Williams J. F. Rifampicin inhibits the growth of some mammalian viruses. Nature. 1969 Apr 26;222(5191):341–345. doi: 10.1038/222341a0. [DOI] [PubMed] [Google Scholar]
- Umezawa H., Mizuno S., Yamazaki H., Nitta K. Inhibition of DNA-dependent RNA synthesis by rifamycins. J Antibiot (Tokyo) 1968 Mar;21(3):234–236. doi: 10.7164/antibiotics.21.234. [DOI] [PubMed] [Google Scholar]